|
| 38048423 | Proteomic Evolution from Acute to Post-COVID-19 Conditions. | J Proteome Res | 2024 |
| 36661450 | Mortality As a Measure of Treatment Effect in Clinical Trials Recruiting Critically Ill Patients. | Crit Care Med | 2023 |
| 37527902 | Outcomes and characteristics of patients hospitalized for COVID-19 in British Columbia, Ontario and Quebec during the Omicron wave. | CMAJ Open | 2023 |
| 37801356 | A Hospital-Wide Open-Label Cluster Crossover Pragmatic Comparative Effectiveness Randomized Trial Comparing Normal Saline to Ringer's Lactate: Protocol and Statistical Analysis Plan of The FLUID Trial. | JMIR Res Protoc | 2023 |
| 37592121 | Distinct host-response signatures in circulatory shock: a narrative review. | Intensive Care Med Exp | 2023 |
| 37591648 | WHO O2CoV2: oxygen requirements and respiratory support in patients with COVID-19 in low-and-middle income countries-protocol for a multicountry, prospective, observational cohort study. | BMJ Open | 2023 |
| 37486186 | Error, Fraud, and Responsibility. | Crit Care Med | 2023 |
| 37888913 | Simvastatin in Critically Ill Patients with Covid-19. | N Engl J Med | 2023 |
| 37877585 | Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials. | JAMA | 2023 |
| 37644556 | Proton pump inhibitors in critically ill mechanically ventilated patients with COVID-19: protocol for a substudy of the Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial. | Trials | 2023 |
| 37539964 | The Modified Clinical Progression Scale for Pediatric Patients: Evaluation as a Severity Metric and Outcome Measure in Severe Acute Viral Respiratory Illness. | Pediatr Crit Care Med | 2023 |
| 37642672 | Correction: Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation Correction: After Resuscitation-2 (RADAR-2) randomised clinical trial. | Intensive Care Med | 2023 |
| 37055859 | Co-designing and pilot testing an infographic to support patients/families through the REMAP-CAP consent process: a mixed-methods study protocol. | Pilot Feasibility Stud | 2023 |
| 36978809 | DJ-1 Deficiency Protects against Sepsis-Induced Myocardial Depression. | Antioxidants (Basel) | 2023 |
| 37208143 | What counts as patient-important upper gastrointestinal bleeding in the ICU? A mixed-methods study protocol of patient and family perspectives. | BMJ Open | 2023 |
| 37340634 | Preventing occludin tight-junction disruption via inhibition of microRNA-193b-5p attenuates viral load and influenza-induced lung injury. | Mol Ther | 2023 |
| 37039790 | Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial. | JAMA | 2023 |
| 37006251 | Editorial: Neutrophil death regulation in critical illness. | Front Immunol | 2023 |
| 36889040 | Long-term physical impairments in survivors of COVID-19-associated ARDS compared with classic ARDS: A two-center study. | J Crit Care | 2023 |
| 36870801 | Definitions, rates and associated mortality of ICU-acquired pneumonia: A multicenter cohort study. | J Crit Care | 2023 |
| 36682909 | Clostridioides difficile infection in mechanically ventilated critically ill patients: A nested cohort study. | J Crit Care | 2023 |
| 36737087 | FLUID trial: a hospital-wide open-label cluster cross-over pragmatic comparative effectiveness randomised pilot trial comparing normal saline to Ringer's lactate. | BMJ Open | 2023 |
| 34112731 | Mesenchymal stromal (stem) cell therapy modulates miR-193b-5p expression to attenuate sepsis-induced acute lung injury. | Eur Respir J | 2022 |
| 35709825 | Use of pragmatic and explanatory trial designs in acute care research: lessons from COVID-19. | Lancet Respir Med | 2022 |
| 35709013 | Intravenous Fluids in Septic Shock - More or Less? | N Engl J Med | 2022 |
| 35802687 | Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: A network meta-analysis. | PLoS One | 2022 |
| 35612454 | The authors reply. | Crit Care Med | 2022 |
| 35440485 | Organ dysfunction and death in patients admitted to hospital with COVID-19 in pandemic waves 1 to 3 in British Columbia, Ontario and Quebec, Canada: a cohort study. | CMAJ Open | 2022 |
| 35608319 | Probiotics in Critical Illness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | Crit Care Med | 2022 |
| 35670454 | ACTIVATION OF THE MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN (MAVS) FOLLOWING LIVER ISCHEMIA/REPERFUSION AND ITS EFFECT ON INFLAMMATION AND INJURY. | Shock | 2022 |
| 35641782 | DJ-1 binds to Rubicon to Impair LC-3 Associated Phagocytosis. | Cell Death Differ | 2022 |
| 35607951 | Renin-Angiotensin System Pathway Therapeutics Associated With Improved Outcomes in Males Hospitalized With COVID-19. | Crit Care Med | 2022 |
| 35534922 | Diversity in the Expressed Genomic Host Response to Myocardial Infarction. | Circ Res | 2022 |
| 35724443 | Monitoring and auditing protocol adherence, data integrity and ethical conduct of a randomized clinical trial: A case study. | J Crit Care | 2022 |
| 35715504 | Redefining critical illness. | Nat Med | 2022 |
| 36470831 | Gaps and opportunities in sepsis translational research. | EBioMedicine | 2022 |
| 36140361 | The End of "One Size Fits All" Sepsis Therapies: Toward an Individualized Approach. | Biomedicines | 2022 |
| 36289153 | Health economic evaluation alongside the Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (E-PROSPECT): a cost-effectiveness analysis. | Can J Anaesth | 2022 |
| 36008455 | Automated in vivo compound screening with zebrafish and the discovery and validation of PD 81,723 as a novel angiogenesis inhibitor. | Sci Rep | 2022 |
| 36216432 | Haemoglobin transfusion threshold in traumatic brain injury optimisation (HEMOTION): a multicentre, randomised, clinical trial protocol. | BMJ Open | 2022 |
| 35191892 | The authors reply. | Crit Care Med | 2022 |
| 34983279 | Perspectives of patients, family members, health professionals and the public on the impact of COVID-19 on mental health. | J Ment Health | 2022 |
| 34951953 | A clinical case definition of post-COVID-19 condition by a Delphi consensus. | Lancet Infect Dis | 2022 |
| 35315874 | Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial. | JAMA | 2022 |
| 34913089 | Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation After Resuscitation-2 (RADAR-2) randomised clinical trial. | Intensive Care Med | 2022 |
| 35143212 | Longitudinal Plasma Proteomics Analysis Reveals Novel Candidate Biomarkers in Acute COVID-19. | J Proteome Res | 2022 |
| 34588274 | Physical, cognitive and mental health outcomes in 1-year survivors of COVID-19-associated ARDS. | Thorax | 2022 |
| 34310901 | Advancing precision medicine for acute respiratory distress syndrome. | Lancet Respir Med | 2022 |
| 33350801 | Toll-Like Receptors, Associated Biochemical Signaling Networks, and S100 Ligands. | Shock | 2021 |
| 33598888 | Intravenous immune globulin in septic shock: a Canadian national survey of critical care medicine and infectious disease specialist physicians. | Can J Anaesth | 2021 |